ArticleScientific reports2021

Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study.

Sheriza Baksh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.